This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2006 Jun;154(6):1216-8.

doi: 10.1111/j.1365-2133.2006.07279.x.

Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia

N Deguchi, T Kawamura, A Shimizu, R Kitamura, M Yanagi, N Shibagaki, H Matsue, S Shimada

PMID: 16704666
DOI: 10.1111/j.1365-2133.2006.07279.x

Case Reports

Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia

N Deguchi et al. Br J Dermatol. 2006 Jun.

. 2006 Jun;154(6):1216-8.

doi: 10.1111/j.1365-2133.2006.07279.x.

Authors

N Deguchi, T Kawamura, A Shimizu, R Kitamura, M Yanagi, N Shibagaki, H Matsue, S Shimada

PMID: 16704666
DOI: 10.1111/j.1365-2133.2006.07279.x

No abstract available

PubMed Disclaimer

Similar articles

Imatinib: a designer drug, another cutaneous complication.
Dickens E, Lewis F, Bienz N. Dickens E, et al. Clin Exp Dermatol. 2009 Jul;34(5):603-4. doi: 10.1111/j.1365-2230.2009.03250.x. Epub 2009 May 26. Clin Exp Dermatol. 2009. PMID: 19486036
Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
Kuraishi N, Nagai Y, Hasegawa M, Ishikawa O. Kuraishi N, et al. Acta Derm Venereol. 2010;90(1):73-6. doi: 10.2340/00015555-0758. Acta Derm Venereol. 2010. PMID: 20107730 Review.
Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Kuwano Y, Asahina A, Watanabe R, Fujimoto M, Ihn H, Tamaki K. Kuwano Y, et al. Int J Dermatol. 2006 Oct;45(10):1249-51. doi: 10.1111/j.1365-4632.2006.02930.x. Int J Dermatol. 2006. PMID: 17040457 No abstract available.
Skin fragility and blistering with imatinib mesylate.
Verma SM, Murphy G. Verma SM, et al. J Eur Acad Dermatol Venereol. 2010 Apr;24(4):496-8. doi: 10.1111/j.1468-3083.2009.03456.x. Epub 2009 Nov 18. J Eur Acad Dermatol Venereol. 2010. PMID: 19925597 No abstract available.
[Adverse effects of imatinib mesylate].
Isshiki I. Isshiki I. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:404-7. Nihon Rinsho. 2007. PMID: 17474438 Review. Japanese. No abstract available.

See all similar articles

Cited by

Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.
Mezentsev AV, Bruskin SA, Soboleva AG, Sobolev VV, Piruzian ES. Mezentsev AV, et al. Int J Biomed Sci. 2013 Sep;9(3):112-22. Int J Biomed Sci. 2013. PMID: 24170986 Free PMC article.
Nail lichen planus associated with imatinib mesylate.
Axler E, Loesch E, Vaidya T, Neubauer Z, Lipner SR. Axler E, et al. JAAD Case Rep. 2025 Jan 31;58:25-28. doi: 10.1016/j.jdcr.2024.12.039. eCollection 2025 Apr. JAAD Case Rep. 2025. PMID: 40099167 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information